Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient satisfaction with fentanyl nasal spray for breakthrough pain
NL-OMON28012Recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Jul 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fentanyl in breakthrough pain and pain, sponsored by Maastricht University Medical Center+. Primary endpoint: Patient satisfaction with fentanyl nasal spray. Started Jul 2010; status: recruiting.
02
Drugs
fentanyl
03
Conditions
breakthrough painpain
Beyond the preview
Go deeper on NL-OMON28012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28012.